Kathy Giusti, M.B.A. ’85, founder and CEO of the Multiple Myeloma Research Foundation (MMRF), will address this year's imminent graduates of Harvard Business School as Class Day speaker. She founded the MMRF in 1998 after being diagnosed with multiple myeloma. This spring, Time magazine named her one of the "100 most influential people" in the world. Multiple myeloma is a cancer of plasma cells—white blood cells that produce antibodies; it affects from one to four people per 100,000 and constitutes 1 percent of all cancers. Before starting MMRF, Giusti was an executive with pharmaceutical companies, and she has sought to encourage the development of drugs to treat the disease using a business model, rather than an academic model, of drug development. The MMRF is the world's top funder of myeloma research: it has raised more than $165 million to fund research.
Multiple myeloma research crusader Kathy Giusti to speak at HBS Class Day
Multiple myeloma research crusader Kathy Giusti to speak at HBS Class Day
The founder of the Multiple Myeloma Research Foundation will speak at Harvard Business School Class Day.
You might also like
Garber to Serve as Harvard President Beyond 2027
A once-interim appointment will now continue indefinitely.
Harvard Students, Alumna Named Rhodes and Marshall Scholars
Nine Rhodes and five Marshall scholars will study in the U.K. in 2026.
Harvard’s Financial Challenges Lead to Difficult Choices
The University faces the consequences of the Trump administration—and its own bureaucracy
Most popular
Explore More From Current Issue
On Weekends, These Harvard Math Professors Teach the Smaller Set
At Cambridge Math Circle, faculty and alumni share puzzles, riddles, and joy.
The 1884 Cannibalism-at-Sea Case That Still Has Harvard Talking
The Queen v. Dudley and Stephens changed the course of legal history. Here’s why it’s been fodder for countless classroom debates.